Prostaglandin E2 is Required for BMP4-Induced Mesoderm Differentiation of Human Embryonic Stem Cells.

Bowen Zhang,Lijuan He,Yiming Liu,Jing Zhang,Quan Zeng,Sihan Wang,Zeng Fan,Fang,Lin Chen,Yang Lv,Jiafei Xi,Wen Yue,Yanhua Li,Xuetao Pei

DOI: https://doi.org/10.1016/j.stemcr.2018.01.024

2018-01-01

Stem Cell Reports

Abstract:The accurate control of early cell fate specification during differentiation of human embryonic stem cells (hESCs) is critical for acquiring pure therapeutic cell populations of interest. Bone morphogenetic protein 4 (BMP4) is a key mesoderm inducer from ESCs. However, the molecular mechanism of the mesodermal cell fate decision induced by BMP4 remains unclear. Here, we demonstrate the requirement of a bioactive lipid, prostaglandin E2 (PGE2), for the mesoderm specification from hESCs by BMP4 induction. We show that BMP4 directly regulates the expression of the key enzyme for PGE2 synthesis, COX-1, and promotes PGE2 production. More importantly, in the absence of BMP4, forced COX-1 expression or PGE2 treatment is sufficient to initiate mesoderm specification of hESCs by activation of EP2-PKA signaling and modulation of nuclear translocation of β-catenin. Together, our findings provide insights into the critical role of BMP regulation of PGE2 synthesis and its downstream signaling in initiating mesoderm commitment of hESCs.